However, the expression, distribution, and clinical significance of CD103+ tumor-infiltrating lymphocytes (TILs) in esophageal squamous cell carcinoma (ESCC) remain unclear. The gene discussed is ITGAE; the disease is esophageal squamous cell carcinoma.